Widely used by the agri-food industry, food additives are mainly found in the ultra-processed products sold in our ...

Two undergraduate medicine students at University of Galway have led a major study examining how cardioprotective ...

As the obesity rate among people with type 1 diabetes rises, patients are taking popular weight loss drugs like Ozempic—and ...

Insulin: In 2019, employer plan participants who used insulin spent an average of $82 per month out-of-pocket on their ...

A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type ...

GLP-1 receptor agonists and SGLT2 inhibitors are associated with a lower risk of dementia, suggesting these drugs may have a ...

Medtronic (NYSE:MDT) has appointed a former Dexcom leader as the new head of Americas for its Diabetes business unit.

Chief Executive Tim Wentworth said the second-quarter results reflected cost management and improvement in U.S. healthcare, though partially offset by weaker front-rend results in U.S. retail pharmacy ...

Chief Executive Tim Wentworth said the second-quarter results reflected cost management and improvement in U.S. healthcare, though partially offset by weaker front-rend results in U.S. retail pharmacy ...

Walgreens , which is in the process of being taken private by Sycamore Partners, beat Wall Street estimates for quarterly ...

Two studies suggested the diabetes/weight-loss drug may have a beneficial side effect—but more work is needed to confirm this.

New research suggests that GLP-1 drugs like Ozempic and Wegovy, commonly used for diabetes and weight loss, may also reduce ...